TuesdayJul 09, 2013 8:00 am

Soligenix, Inc. (SNGX) Enters into Commercial Collaboration with SciClone Pharmaceuticals in China for SGX942

Soligenix, a clinical-stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures, has established a personalized medicine collaboration with SciClone Pharmaceuticals in SNGX’s oral mucositis clinical program with SGX942 for the treatment of oral mucositis (OM). Soligenix is developing SGX942 to address the unmet medical need of OM in solid tumor patients, especially those with head and neck cancer. OM affects approximately 90,000 head and neck cancer patients each year in the U.S. SGX942 recently received investigational new drug (IND) clearance from the U.S. Food and Drug Administration (FDA) and is prepared to initiate a phase…

Continue Reading

MondayJul 08, 2013 5:07 pm

Players Network (PNTV) is “One to Watch”

Players Network is focused on using its proprietary cloud-based technology to create, distribute, market, and monetize branded Digital Lifestyle Networks that attract large, targeted audiences. Incorporating the best components of Hulu, YouTube, Facebook, and Groupon, PNTV’s scalable NexGenTV platform is able to launch an unlimited number of digital channel destinations in any category. The company currently distributes its programming to approximately 27 million cable, satellite, and IPTV homes via Comcast, DirecTV, Verizon, and other networks. Players Network aims to drive viewers to its new, interactive platform by tapping into its existing, widespread distribution. This game-changing strategy advances traditional distribution methods…

Continue Reading

MondayJul 08, 2013 4:46 pm

GRILLiT, Inc. (GRLT) Making Waves in Florida with Healthy, Made-To-Order Casual Dining Menu

GRILLiT is turning heads in the food service space with an exceptional brand of fast-casual restaurants that are changing people's pre-conceived notions about the potential for delicious America, Asian Fusion, and Latin American style lunch and dinner menus, including sumptuous grilled foods, to also be healthy. One of the keys to the company's success thus far has been to use the freshest ingredients for their made-to-order lunch and dinner menu, which is also made available as carry-out or for event catering. The other key has been a mix of casual dining atmosphere and intelligent location of the company's venues in…

Continue Reading

MondayJul 08, 2013 4:24 pm

The Aristocrat Group Corp. (ASCC) Seeks New “Top Drink”

It is surprising to many that vodka, now the most popular hard liquor in America, was almost unknown in the U.S. prior to World War II. The first U.S. distillery wasn’t even set up until the 1930s, and it was only well after the War, in the 50s and 60s, that vodka began to get significant recognition in the U.S. In a food and beverage world where taste dominated, it was vodka’s unique lack of taste that made it the perfect mixer and helped drive its popularity. Vodka can mix with virtually anything, achieving dramatically different creations depending upon the…

Continue Reading

MondayJul 08, 2013 2:28 pm

Rafarma Pharmaceuticals, Inc. (RAFA) Targets Fair Share of Russia’s Rapidly Growing Pharmaceutical Market

Rafarma Pharmaceuticals constructed and now operates a 270,000-square foot multi-purpose pharmaceutical facility in Russia in direct response to the Russian Government’s plan to significantly advance the domestic pharmaceutical industry in the Russian Federation. In a recent video interview with the QualityStocks Production team, Rafarma CEO Sergey Brunsnitsyn details the operations and qualification of the production plant, how it meets world standards in the field of pharmaceuticals and industrial construction, and the company’s strategy to secure 5 percent of market share in the Russian pharmaceuticals market by 2017. “The strategies of the company, the professional team, the modern production facilities and…

Continue Reading

MondayJul 08, 2013 2:18 pm

Cell Therapeutics, Inc. (CTIC) PIXUVRI® Granted Market Access in Italy, Provides Solution for Multiply Relapsed, Aggressive non-Hodgkin Lymphoma

Cell Therapeutics, the Seattle-based biopharma developer focused on targeted oncology therapeutics which cover a broad spectrum of blood-related cancers, was excited to report today that their revolutionary anti-lymphoma compound, PIXUVRI® (Pixantrone), has been cleared for access to Italian markets by the nation's primary regulatory body, the AIFA (Italian Medicines Agency), following the adoption last year in May by the EC (European Commission) of conditional marketing authorization status for the EU. PIXUVRI's original market authorization in the EU, as a monotherapy for adults with aggressive B-cell NHL (non-Hodgkin lymphoma), where the patient has failed prior therapy lines, is extended here via…

Continue Reading

MondayJul 08, 2013 12:25 pm

GNCC Capital, Inc. (GNCP) Business Model Supported by Industry Experienced Leadership

GNCC Capital is focused on its gold and three silver exploration projects in Arizona. The company’s team of geologists supervises the exploration program designed to prove up reserves through geological surveys and drilling programs. While the company’s primary focus is gold exploration, it is also seeking opportunities in other minerals and aims to grow through acquisitions of promising gold mining properties in the United States. GNCC Capital’s business model also allows for consideration of serious joint ventures on any of its portfolio assets. Company CEO Nicolaas Edward “Ted” Blom has more than 25 years of experience in mining and energy,…

Continue Reading

MondayJul 08, 2013 12:20 pm

VentriPoint Diagnostics Ltd. (VPTDF) Expands Target Market to Include Pulmonary Hypertension

A unique ultrasound-based system for performing right heart analysis, developed by VentriPoint Diagnostics and now used in various hospitals around the world, is also being developed and introduced as a superior approach to diagnose pulmonary hypertension (PH), an unhealthy increase in blood pressure in the pulmonary artery or pulmonary vein which can lead to a variety of problems, up to and including heart failure. The VentriPoint VMS system, called Angelo, uses 2-dimensional ultrasound data, together with a patented system called Knowledge-Based Reconstruction (KBR) for analyzing that ultrasound data. The result is an information-rich 3-dimensional model of the heart. For right…

Continue Reading

MondayJul 08, 2013 10:58 am

Mabwe Minerals Inc. (MBMI) Targets the Middle East, Europe, and More

Mabwe Minerals, together with a number of key partners, is busy developing a world-class deposit of barite (BaSO4) in Zimbabwe in southern Africa. The company’s Dodge Mine project in northeast Zimbabwe is the current focus, where ASCON validation studies of just one part of the property indicate 411,000 tons of barite and 531,000 tons of limestone, representing a current market value of approximately $79 million, just for a start. Baker Hughes, Inc., one of the world’s top-tier oilfield service companies, has already lined up as a major buyer, looking for roughly 3 million metric tons at 220,000 tons annually for…

Continue Reading

MondayJul 08, 2013 10:34 am

Joe’s Jeans Inc. (JOEZ) Video Chart for Monday, July 8, 2013

JOEZ is holding a firm support level around $1.50 and the indicators are trying to turn. The chart faces a challenge at static and dynamic resistance at $1.70, but a break above that level could signal a run at 52-week highs. To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts Let us hear your thoughts below:

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered